Estimates Revisions S&P Global Inc. Sao Paulo
Stocks
SPGI34
BRSPGIBDR009
Professional Information Services
|
Delayed
Sao Paulo
01:06:49 05/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 62.97 BRL | -0.90% |
|
-1.27% | -23.46% |
| 05/09 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 04/09 | Services Sector Growth Accelerates Amid Strong Demand, ISM, S&P Surveys Show | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
S&P Global, Inc.(SPGI)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
S&P Global, Inc.(SPGI)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
S&P Global, Inc.(SPGI)
EBIT
Dividend / Share (DPS)
Data source:
S&P Global, Inc.(SPGI)
Cash or Net Debt
- Stock Market
- Stocks
- SPGI Stock
- SPGI34 Stock
- Consensus S&P Global Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
















